Type 2 Diabetes

Diabetes may be a common condition but there are still some parts of the condition that are misunderstood even by doctors and health care professionals treating these patients.

Thanks to the smartphone not only can patients better monitor their diabetes but the same information can be sent to parents of children to help ensure they are safe and healthy throughout the day.

While the number of treatments for type 1 diabetes lags behind those for type 2 there is still a lot of work being done to help these patients thanks in large part to technological advances.

Patients with type 1 or type 2 diabetes mellitus can experience modest exocrine pancreatic insufficiency and moderate-to-severe subclinical pancreatic fibrosis even in the absence of pancreatitis.

Our March list of news and research includes studies on obesity risks, hypothyroidism management, and recent findings on prediabetes.

Since controlling diabetes has an effect on breast tissue, diabetes treatment may lessen breast cancer risk, a Danish study found.

When it comes to diabetes screening, big data may uncover more cases. A California team came up with a new algorithm that assesses risk.

Why would the pancreas need a bacteria-killing protein when it isn’t normally exposed to bacteria? A Canadian team has the answer.

Predictive models of type 2 diabetes risk may not work as well in assessing African American patients, a study found.

A new study looks at the role of an SGLT2 inhibitor on cardiovascular outcomes in type 2 diabetes patients.

Whether used as monotherapy or dual therapy, is there an advantage to using one specific SGLT2 inhibitor over another?

Since one-third of patients with diabetes develop neuropathy, prevention and management are top concerns for endocrinologists.

Many trainers recommend intermittent high-intensity exercise (IHE) – bouts of periodic supramaximal effort during low-to-moderate intensity activity for the general population.

How much of an effect does sedentary behavior have on glucose metabolism status and metabolic syndrome?

Despite a considerable gap between the number of patients who require a transplant and the number of organs available those patients fortunate enough to receive the lifesaving organs are seeing greater success from the procedure.

With hundreds of thousands of people in the United States undergoing dialysis the field of nephrology is working hard to keep these patients as healthy as possible in hopes of getting them to the point of kidney transplant.

There is no shortage of people in need of a kidney transplant but a considerable shortage in the number of organs available to these patients. Despite that health care professionals in nephrology are determined to provide their patients the highest quality of life possible in spite of these challenges.

Studies of cancer risks with diabetes have been comprised mostly of people with T2DM, leaving the links between cancer and T1DM relatively unknown.

Many factors and competing responsibilities dictate how many patients you can see in one day. What’s your ideal number?

Researchers discovered a method to control insulin assembly with great precision, possibly opening the door to creating more personalized medications.

Researchers examined a high-risk patient population to determine the prevalence and risk factors of diabetic retinopathy.

Pediatric diabetes and kidney complications related to it are on the rise, a new analysis of insurance data shows.

What role does adiposity play in insulin sensitivity and secretion in children? Is a healthy lifestyle just as important in children as in adults?

Unlike typical Western patients, type 2 diabetes patients in Asia tend to have lower BMIs. Does this mean responses to GLP-1 RAs differ as well?

Overall, three drugs available to treat diabetic macular edema all did a good job, researchers found in a national clinical trial. One costs $60 per injection, the others cost over $1,200 and $1,850. But the most expensive one did best in a subset of patients.

The LEADER trial of GLP-1 RA liraglutide examined anthropometric measures of adiposity and cardiovascular risk in type 2 diabetes patients.

In a time when obesity and cardiovascular disease are growing problems doctors are also working to combat diabetes at the same time. This presents opportunities for care as well as challenges in addressing the various concerns of their patients.

When diabetes first became a concern in the medical community the numbers were lower, but the consequences were much more severe. Today, many more people are diagnosed with types one and two diabetes but the treatment options are much safer and more effective.

Why are necessities for diabetes management, particularly insulin, unattainable to many globally, and how can we improve availability?